Ulipristal acetate use in Alberta, Canada, steadily increased since approval, with equitable rural and urban access. First-year uptake appeared to have a lag compared to other new medications, suggesting adoption barriers. Clinician awareness, patient education, and policy support remain essential to ensure equitable access to this highly effective emergency contraception.
Biderman et al. (Thu,) studied this question.